Literature DB >> 24001418

Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.

Dinka Pavičić Baldani1, Lana Škrgatić, Zrinka Bukvić Mokos, Iva Trgovčić.   

Abstract

Clinical traits associated with androgen, acne and hirsutism, are important diagnostic features of polycystic ovary syndrome (PCOS). As androgens are necessary for the development of cutaneous signs of PCOS, patients with severe forms of clinical hyperandrogenism are expected to present with higher levels of plasma androgens. This relationship has not been well established and studies examining the relationship have produced inconsistent results. The aim of this study was to analyze the correlation between the severity of clinical traits caused by androgen, acne and hirsutism, with plasma levels of androgens in Croatian women diagnosed with PCOS. One hundred and forty-five women of reproductive age with isolated acne (n=61) or isolated hirsutism (n=84), oligo/amenorrhea and polycystic morphology of the ovaries were enrolled in the study. Acne grade, hirsutism grade, body mass index (BMI) and waist to hip ratio (WHR) were recorded. Hormonal profiles were measured and assessment of insulin resistance was performed. There were no significant associations between acne severity and BMI, WHR and examined hormonal and insulin resistance parameters. There was a significant correlation between sex-hormone binding globulin (SHBG) and free testosterone levels and the severity of hirsutism (ρ=-0.611, P<0.001 and ρ=0.337, P=0.002, respectively). No significant association was found between the hirsutism grade and other hormonal and metabolic parameters examined. In conclusion, acne severity in PCOS patients is not linearly associated with serum androgen levels; therefore, their levels should not be used to determine the dose of anti-androgen therapy. The observed negative correlation between serum SHBG levels and the degree of hirsutism suggests that hormonal contraception, which elevates SHBG, should be used as primary therapy in hirsute PCOS patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24001418

Source DB:  PubMed          Journal:  Acta Dermatovenerol Croat        ISSN: 1330-027X            Impact factor:   1.256


  5 in total

1.  Revisiting the role of testosterone: Are we missing something?

Authors:  Vineet Tyagi; Michael Scordo; Richard S Yoon; Frank A Liporace; Loren Wissner Greene
Journal:  Rev Urol       Date:  2017

2.  Associations of insulin resistance, sex hormone-binding globulin, triglyceride, and hormonal profiles in polycystic ovary syndrome: A cross-sectional study.

Authors:  Bahia Namavar Jahromi; Niloofar Borzou; Mohammad Ebrahim Parsanezhad; Zahra Anvar; Parvin Ghaemmaghami; Soudabeh Sabetian
Journal:  Int J Reprod Biomed       Date:  2021-08-16

3.  Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.

Authors:  Seddigheh Esmaeilzadeh; Maryam Ghanbari Andarieh; Reza Ghadimi; Mouloud Agajani Delavar
Journal:  Glob J Health Sci       Date:  2014-09-28

4.  How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities.

Authors:  Yu-Yang Wang; Shang-Wei Li; Shan Luo; Lang Qin; Xun Zeng; Lei Li; Xiao-Hong Li
Journal:  Biomed Res Int       Date:  2019-02-03       Impact factor: 3.411

5.  Association between biochemical hyperandrogenism parameters and modified Ferriman-Gallwey score in patients with hirsutism in Basrah (Southern Iraq).

Authors:  Rudha Naser Hussein; Khalil Ismail Al Hamdi; Abbas Ali Mansour
Journal:  Postepy Dermatol Alergol       Date:  2021-01-17       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.